Medicare spent $752 million on discarded drugs in 2019, up from $725 million the year before.
After examining CMS’ spending data, the researchers found that most of the wasted drugs were chemotherapy or oncology treatments. They said most of the waste is a result of single-dose vials or medication containers that include higher doses than necessary to treat the average patient.
In order to illustrate what the $2.1 billion could have paid for instead of discarded drug doses, the researchers laid out a few alternatives. That amount of money could cover the costs of 46.6 million flu shots, a year’s-worth of insulin for 5 million Medicare Part D beneficiaries with diabetes or the total annual household spending for over 168,000 families of four on an employer health insurance plan.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.